Singapore markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
11.21+0.12 (+1.08%)
At close: 04:00PM EDT
11.24 +0.03 (+0.27%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.09
Bid10.60 x 1300
Ask11.24 x 1000
Day's range11.04 - 11.32
52-week range6.78 - 11.34
Avg. volume13,461,358
Market cap12.449B
Beta (5Y monthly)1.31
PE ratio (TTM)N/A
EPS (TTM)-0.56
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date27 Nov 2017
1y target est10.73
  • Motley Fool

    Why Teva Stock Trounced the Market on Friday

    The stock of Teva Pharmaceutical Industries (NYSE: TEVA) closed out the trading week in style, popping by almost 6% on Friday. The generic-drug specialist was the subject of a recommendation upgrade from a noted financial institution, hence the share price rise. Analyst Jason Gerberry from the bank's securities unit raised his recommendation on Teva from neutral to buy.

  • Motley Fool

    Is This Rare Berkshire Hathaway Miscue Finally a Buy?

    Berkshire Hathaway cut bait with the struggling drugmaker Teva Pharmaceutical Industries in late 2021.

  • Reuters

    AbbVie to pay up to $2.37 billion to settle U.S. opioid claims

    (Reuters) -AbbVie Inc has agreed to pay up to $2.37 billion to resolve thousands of U.S. lawsuits against its Allergan unit over the marketing of opioid painkillers, state officials announced on Friday. If finalized, the deal could end more than 3,000 lawsuits by state and local governments around the country. "We've worked hard to get the best result for Americans harmed by the opioid crisis, and it's rewarding to take another step in the right direction," Iowa Attorney General Tom Miller, who led negotiations with the company, said in a statement.